Back To Schedule
Tuesday, June 20 • 2:00pm - 3:15pm
#248: Building the Medical Strategy and Tactics

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session
Level: Intermediate
CE: CME 1.25; IACET 1.25; RN 1.25

This session will focus on how to develop a comprehensive medical plan for your medical affairs unit. Speakers will discuss key considerations, such as effective collaboration and value add to clinical development, research and development, and commercialization groups.

Learning Objectives

Discuss key considerations and strategies for medical manager/directors when developing medical plans.


Anny Chen, PharmD


How to Build Medical Strategy from the Perspective of a Biotech Company
Chung H. (Lou) Lu, PharmD

Scientific Communications Planning
Bhakti Kshatriya, PharmD

Developing Medical Strategy and Tactics With a Focus on Data Generation
Fabrizio Tondolo, MD


Anny Chen

Senior Director, Global Scientific Communications, Novartis Pharmaceuticals Corporation
avatar for Bhakti Kshatriya

Bhakti Kshatriya

Founder, Publication Practice Counsel, Truposha, LLC
Dr. Kshatriya is author, speaker & medical communications expert with over 20 yrs industry experience, incl. prelaunch, launch & end of product lifecycle Rx-to-OTC switch. She recently published book Recoding Scientific Publishing: Raising the Bar in an Era of Transformation, providing... Read More →

Lou Lu

Senior Director - Medical Affairs and Medical Information, Otonomy, Inc
A Senior Medical Affairs Professional with a 10-year track record of taking pharmaceutical products from Phase 3 to launch and through the post-marketing lifecycle. A strong work ethic and instinctive focus on detail with extensive pharma/biotech Medical Affairs knowledge. A self-starter... Read More →
avatar for Chung H. (Lou) Lu

Chung H. (Lou) Lu

Senior Director - Medical Affairs and Medical Information, Otonomy, Inc
Lou is Sr. Director of Medical Affairs at Otonomy, a biopharmaceutical company focused on novel ear disorder therapies. Prior to Otonomy, Lou was Director of Medical Affairs at Cadence Pharmaceuticals launching OFIRMEV, intravenous acetaminophen. Before Cadence, Lou spent 6 years... Read More →
avatar for Fabrizio Tondolo

Fabrizio Tondolo

Global Medical Affairs Lead, Infectious Disease, Merck & Co., Inc.
Fabrizio is Associate Vice President Hospital & Specialty in US Medical Affairs in Merck. He received his MD degree at the University of Bologna (Italy) and, after two years of medical practice, joined Merck in 1995. Through his career in Merck, he has lived in Italy, Switzerland... Read More →

Tuesday June 20, 2017 2:00pm - 3:15pm CDT
S401a McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616
  03: MedAffairs-SciComm, Session